Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Typesort descending Therapeutic or Technology Institution Stage Project Objective Details
Wounds, ulcers Small molecule therapy UCLA
IND
BrainXell Therapeutics
UCLA
Colon Cancer Tachyon Therapeutics, Inc
Clinical Trial, Phase 1 or Phase 1/2
Muscular Dystrophy Protein/peptide therapy Juvena Therapeutics Inc.
Pre-IND/IDE or Equivalent
COH
Prostate Cancer Gene-modified, personalized cell therapy USC
Pre-IND/IDE or Equivalent
B cell cancers Gene-modified, personalized cell therapy UC Davis
Pre-IND/IDE or Equivalent
Eureka Therapeutics, Inc.
Neurological Disorders Gene Therapy, cell free Mahzi Therapeutics
Pre-IND/IDE or Equivalent
Heart failure Gene Therapy, cell free Tenaya Therapeutics, Inc.
Development Candidate
Retinitis Pigmentosa Therapeutic Approach jCyte
Clinical Trial, Phase 2
VxBiosciences inc.
Stanford
USC
Lung Disease, Fibrosis Gene Therapy, cell free Rejuvenation Technologies, Inc.
Pre-IND/IDE or Equivalent
HIV/AIDS Gene Therapy, cell free Excision BioTherapeutics
Clinical Trial, Phase 1 or Phase 1/2
Multiple Myeloma Adult Stem Cell Gene-modified, personalized cell therapy Poseida Therapeutics
Clinical Trial, Phase 1 or Phase 1/2
Melanoma Adult Stem Cell Vaccine UCLA
Proof of Concept
Immune Disease,
Leukocyte Adhesion Deficiency
Adult Stem Cell Gene-modified, personalized cell therapy Rocket Pharmaceuticals, Inc.
Clinical Trial, Phase 1 or Phase 1/2
Multiple Sclerosis Adult Stem Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
Solid Tumors Adult Stem Cell Personalized cell therapy BioEclipse Therapeutics INC.
Clinical Trial, Phase 1 or Phase 1/2
Type 1 diabetes Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders Adult Stem Cell Gene-modified, personalized cell therapy ImmunoVec
Pre-IND/IDE or Equivalent
COVID-19 Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 2
Anemia,
Bone Marrow Transplant and Viral Infection
Adult Stem Cell Immune tolerance/management Stanford
Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Blood Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCSD
IND
Kidney Failure Adult Stem Cell Donor cell therapy Medeor Therapeutics
Clinical Trial, Phase 3
Cystinosis,
Kidney Failure
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Clinical Trial, Phase 1 or Phase 1/2
COVID-19 Adult Stem Cell Vaccine UCLA
Development Candidate, Proof of Concept
Sickle Cell Disease Adult Stem Cell Donor cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Metabolic Disorders Adult Stem Cell Gene-modified, personalized cell therapy Rampart Bioscience
IND
Hypertension, pulmonary arterial Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Brain Cancer,
Breast Cancer
Adult Stem Cell Gene-modified, personalized cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
COVID-19,
Respiratory Disorders
Adult Stem Cell Donor cell therapy Celularity Inc.
Clinical Trial, Phase 1 or Phase 1/2
Neurological Disorders,
Other
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Pre-IND/IDE or Equivalent
Sickle Cell Disease Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Heart Disease Adult Stem Cell Antibody UCLA
Pre-IND/IDE or Equivalent
HIV-related Lymphoma,
HIV/AIDS
Adult Stem Cell Gene-modified, personalized cell therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Cartilage defect Adult Stem Cell Biologic The Stone Research Foundation for Sports Medicine and Arthritis
Development Candidate, Proof of Concept
B cell cancers,
Leukemia
Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Kidney Failure Adult Stem Cell Device UC Davis
Pre-IND/IDE or Equivalent
Severe Combined Immunodeficiency, X-linked (X-SCID) Adult Stem Cell Antibody Jasper Therapeutics, Inc.
Clinical Trial, Phase 1 or Phase 1/2
Lung Disease, Fibrosis Adult Stem Cell Small molecule therapy Rubedo Life Sciences Inc.
Development Candidate, Proof of Concept
IPEX Syndrome Adult Stem Cell Gene-modified, personalized cell therapy ImmunoVec
Pre-IND/IDE or Equivalent
Immune Disease,
X-linked Chronic Granulomatous Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Lung Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Muscle Injury Adult Stem Cell Personalized cell therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2

Pages

Icon for csv export